Suppr超能文献

后负荷降低与心脏功能。全身血管扩张剂作为治疗充血性心力衰竭新方法的生理基础。

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.

作者信息

Mason D T

出版信息

Am J Med. 1978 Jul;65(1):106-25. doi: 10.1016/0002-9343(78)90700-3.

Abstract

Digitalis and diuretics constitute conventional therapy of congestive heart failure, but systemic vasodilators offer an innovative approach in acute and chronic heart failure of decreasing increased left ventricular systolic wall tension (ventricular afterload) by reducing aortic impedance and/or by reducing cardiac venous return. Thus, vasodilators increase cardiac output (CO) by diminishing peripheral vascular resistance (PVR) and/or decrease increased left ventricular end-diastolic pressure (LVEDP) (ventricular preload) by diminishing venous tone. Concomitantly, there is reduction of myocardial oxygen demand, thereby reliably reducing angina pectoris in coronary disease, and potentially limiting infarct size and ischemia provided systemic arterial pressure remains normal. The vasodilators produce disparate modifications of cardiac function depending upon their differing alterations of preload versus impedance: nitrates principally cause venodilation (decrease LVEDP); nitroprusside, phentolamine and prazosin produce balanced arterial and venous dilation (decrease LVEDP and increase CO) provided left ventricular filling pressure is maintained at the upper limit of normal; whereas hydralazine predominantly effects arteriolar dilation (increases CO). With depressed CO plus highly increased LVEDP and increased PVR, nitrates also induce some increase of CO by reducing PVR. Combined nitroprusside and dopamine synergistically enhance CO and decrease LVEDP. Mechanical counterpulsation aids nitroprusside in acute myocardial infarction. The 30-minute venodilator action of sublingual nitroglycerin is extended for 4 to 6 hours by cutaneous nitroglycerin ointment, by sublingual and oral isosorbide dintrate, and by oral pentaerythritol tetranitrate and sustained-release nitroglycerin capsules. Ambulatory oral vasodilator therapy is provided by long-acting nitrates (relieve pulmonary congestion); hydralazine (improves fatigue); prazosin alone, combined nitrate-hydralazine combined prazosin-hydralazine (improve both dyspnea and fatigue).

摘要

洋地黄和利尿剂是充血性心力衰竭的传统治疗方法,但全身血管扩张剂为急慢性心力衰竭提供了一种创新方法,即通过降低主动脉阻抗和/或减少心脏静脉回流来降低升高的左心室收缩期壁张力(心室后负荷)。因此,血管扩张剂通过降低外周血管阻力(PVR)来增加心输出量(CO),和/或通过降低静脉张力来降低升高的左心室舒张末期压力(LVEDP)(心室前负荷)。同时,心肌需氧量减少,从而可靠地减轻冠心病中的心绞痛,并且只要体动脉压保持正常,就有可能限制梗死面积和缺血。根据血管扩张剂对前负荷与阻抗的不同改变,它们会对心脏功能产生不同的影响:硝酸盐主要引起静脉扩张(降低LVEDP);硝普钠、酚妥拉明和哌唑嗪可产生平衡的动脉和静脉扩张(降低LVEDP并增加CO),前提是左心室充盈压维持在正常上限;而肼屈嗪主要作用于小动脉扩张(增加CO)。在CO降低、LVEDP和PVR高度升高的情况下,硝酸盐还可通过降低PVR诱导CO有所增加。硝普钠和多巴胺联合使用可协同增强CO并降低LVEDP。机械性反搏在急性心肌梗死中辅助硝普钠治疗。舌下硝酸甘油30分钟的静脉扩张作用可通过皮肤硝酸甘油软膏、舌下和口服二硝酸异山梨酯、口服四硝酸戊四醇酯和缓释硝酸甘油胶囊延长至4至6小时。长效硝酸盐(缓解肺充血)、肼屈嗪(改善疲劳)、单独使用哌唑嗪、硝酸盐与肼屈嗪联合使用、哌唑嗪与肼屈嗪联合使用(改善呼吸困难和疲劳)可提供门诊口服血管扩张剂治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验